InvestorsHub Logo
Followers 205
Posts 9789
Boards Moderated 6
Alias Born 10/02/2010

Re: laraz5 post# 18202

Sunday, 08/12/2018 2:31:09 AM

Sunday, August 12, 2018 2:31:09 AM

Post# of 21373
Uh huh...this has already been covered.

Oncolix owes 1.5 million for an expired contract to BioVectra



Nope. That is false.

How many shares on ONCX does BioVectra currently own?



10,000,000.

This is current information in SEC docs. Probably more reliable than PRs that are almost 10 years old when Oncolix was a private company with grants from the Susan G. Komen Foundation and the U.S. governement.

Dale Zajicek might go to jail if while he headed BioVectra he made an agreement with promises of future employment with the exact people he made an agreement with, tough to prove but it could have happened?


LOL nope. It didn’t happen.

Dale is not an Oncolix employee, he is an uncompensated BOD member.

He represents a 10,000,000 share voting block owned by the BioVectra parent company Mallinckrodt PLC NYSE: MNK.

NYSE:MNK subsidiary Biovectra holds 10,000,000 common shares of ONCX with no preferreds to offset future dilution or common stock reverse splits as predicted by some.

If I am gonna be a loser victim of a LARP, so will NYSE:MNK, the ONCX CEO, Michael Redman and dozens of accredited investors, who some claim are willing to surrender their control of the company to a few note holders.

Comfy? Previews are over...Lets chat again soon.

GLTA, IMO and FWIW.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.